{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01028495: Phase 2 Interventional Completed Metastatic Pancreatic Cancer
(2009)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:intismeran autogene [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03375047: Phase 1/Phase 2 Interventional Unknown status Cystic Fibrosis
(2018)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:ontasameran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01578655: Phase 3 Interventional Completed Prostate Cancer
(2012)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04588428: Phase 2 Interventional Completed Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
(2021)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:cofirasersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03334617: Phase 2 Interventional Active, not recruiting Non-Small Cell Lung Cancer
(2017)
Source URL:
Class:
NUCLEIC ACID